Please login to the form below

Not currently logged in
Email:
Password:

Israel

This page shows the latest Israel news and features for those working in and with pharma, biotech and healthcare.

Sanofi, Regeneron's Libtayo shows marked reduction in risk of death in cervical cancer patients

Sanofi, Regeneron's Libtayo shows marked reduction in risk of death in cervical cancer patients

Recurrent or metastatic cervical cancer is notoriously difficult to treat and has no approved standard of care after first-line chemotherapy," said Israel Lowy, senior vice president, translational and clinical sciences,

Latest news

More from news
Approximately 3 fully matching, plus 125 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Travel in the time of COVID Travel in the time of COVID

    Transmissibility is a secondary outcome, and we are unlikely to get those data until well into the summer (although some early data out of Israel and from Astra-Zeneca/Oxford look

  • Remote Patient Monitoring in the COVID-19 Era and Beyond

    We also explored how Oxitone is being used to remotely supervise quarantined residents amidst the COVID-19 pandemic in Israel, the barriers to all high-risk chronic disease patients accessing “remote

  • Oradit Ido talks about the Unique Israeli Entrepreneurial Ecosystem

    Orado provides an overview of why she believes Israel is unique in its approach to innovation. ... With a history of overcoming challenges, a people who pride themselves on their chutzpe (audaciousness), and a fast paced culture, she explains why she

  • Competition from within

    Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘BRIC’ markets (Brazil,

  • Do you speak Human? Do you speak Human?

    A recent white paper published by Quintiles stated that, while the MENA region (excluding Israel) currently hosts only about 0.4% of clinical trial sites and patients, its percentage of global

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics